✉news ScienceBiology first seen 2 d ago, last 27 min ago, peak #3
Investors turn to the age of bioconvergence
Original: Investing in the age of bioconvergence
Private equity coverage highlights the rise of bioconvergence as an investment theme, where biology merges with technology fields such as AI, engineering and materials science. The discussion centers on how buyout and growth investors are positioning portfolios to capture opportunities at the intersection of life sciences and tech, and what risks and returns the nascent sector may hold.
Why now: Buyout and private equity audiences are weighing bioconvergence as an emerging investment theme.
Rank over time, top of the chart is #1. 6 snapshots from 8 h ago to 27 min ago.
Evidence
- Investing in the age of bioconvergence · PEI Private Equity
- Investing in the age of bioconvergence · Buyouts
API: https://socialmediatrends-api.osmike.com/v1/trends/3262210